Sheng Yan

机构：Shanxi Medical University, Second Hospital of Shanxi Medical University · ORCID：0000-0001-7795-8725

发表论文 37 篇 · 总被引 551 次 · h-index 14

代表论文

• Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis (2018 · OncoTargets and Therapy · 被引 34)
• Relationship between ADAMTS4 and carotid atherosclerotic plaque vulnerability in humans (2017 · Journal of Vascular Surgery · 被引 33)
• High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors (2021 · BMC Cancer · 被引 32)
• Molecular Mechanism and Approach in Progression of Meningioma (2020 · Frontiers in Oncology · 被引 26)
• HGF/c-Met Axis: The Advanced Development in Digestive System Cancer (2020 · Frontiers in Cell and Developmental Biology · 被引 24)
• Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway (2024 · Lipids in Health and Disease · 被引 23)